Kumarasamy et. al. (2010). „Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study”. The Lancet Infectious Diseases. DOI:10.1016/S1473-3099(10)70143-2.
Karthikeyan K, Thirunarayan MA, Krishnan P (July 2010). „Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India”. J Antimicrob Chemother. DOI:10.1093/jac/dkq273. PMID20650909.
Bax BD et al. (2010-08-04). „Type IIA topoisomerase inhibition by a new class of antibacterial agents”. Nature. DOI:10.1038/nature09197. (primary source)
Miriagou V, Cornaglia G, Edelstein M, et al. (February 2010). „Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues”. Clin. Microbiol. Infect.16 (2): 112–22. DOI:10.1111/j.1469-0691.2009.03116.x. PMID20085605.
Nordmann P, Cuzon G, Naas T (April 2009). „The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria”. Lancet Infect Dis9 (4): 228–36. DOI:10.1016/S1473-3099(09)70054-4. PMID19324295.
Cuzon G, Naas T, Nordmann P (2010). „KPC carbapenemases: what is at stake in clinical microbiology?” (French). Pathol Biol (Paris)58 (1): 39-45. PMID19854586.
Karthikeyan K, Thirunarayan MA, Krishnan P (July 2010). „Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India”. J Antimicrob Chemother. DOI:10.1093/jac/dkq273. PMID20650909.